Free Float 59,17 %
Shares Float 3,77 B
Shares Outstanding 6,38 B
Jiangsu Hengrui Medicine Co., Ltd. Share · CNE0000014W7 (XSHG) China · Healthcare — real-time prices and quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Jiangsu Hengrui Medicine Co., Ltd.
No Price
Closing Price XSHG 03.07.2026:
54,45 CNY
03.07.2026 07:00
Current Prices from Jiangsu Hengrui Medicine Co., Ltd.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
 SSE |
600276.SS
|
CNY
|
03.07.2026 07:00
|
54,45 CNY
| 0,96 CNY
+1,79 %
|
Share Float & Liquidity
Invested Funds
The following funds have invested in Jiangsu Hengrui Medicine Co., Ltd.:
Fund | Vol. in million 10.899,65 | Percentage (%) 4,63 % |
Fund | Vol. in million 12.770,65 | Percentage (%) 1,69 % |
Fund | Vol. in million 19.418,04 | Percentage (%) 0,92 % |
Fund | Vol. in million 8.138,94 | Percentage (%) 0,81 % |
Fund | Vol. in million 4.524,17 | Percentage (%) 0,68 % |
Company Profile for Jiangsu Hengrui Medicine Co., Ltd. Share
Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes medicine worldwide. The company is developing Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403 for oncology, metabolic, pain, autoimmune, and other indications. The company was founded in 1970 and is based in Lianyungang, China.
Company Data
Name Jiangsu Hengrui Medicine Co., Ltd.
Company Jiangsu Hengrui Medicine Co., Ltd.
Website
https://www.hrs.com.cn
Primary Exchange
SSE
SSE
ISIN CNE0000014W7
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Piao Yang Sun
Market Capitalization 341 Mrd.
Country China
Currency CNY
Employees 20,2 T
Address 38 Huanghe Rd Eco & Tech Dev Park, 222000 Lianyungang
IPO Date 2000-10-18
Key Ratios
Dividend
Dividend Yield 0,37 %
Dividend per Share 0,20 CNY
Payout Ratio 15,69 %
Valuation
P/E Ratio 42,79x
P/B Ratio 5,55x
P/S Ratio 10,48x
P/FCF Ratio 39,98x
Margins
Gross Margin 86,24 %
Operating Margin 27,54 %
Net Margin 24,93 %
As of 03.07.2026
Dividends from 'Jiangsu Hengrui Medicine Co., Ltd.'
| Ex-Date | Dividend per Share |
|---|---|
| 27.05.2026 | 0,20 CNY |
| 23.05.2025 | 0,20 CNY |
| 12.07.2024 | 0,20 CNY |
| 08.06.2023 | 0,16 CNY |
| 05.07.2022 | 0,16 CNY |
| 10.06.2021 | 0,17 CNY |
| 25.05.2020 | 0,23 CNY |
| 28.03.2019 | 0,22 CNY |
| 30.05.2018 | 0,29 CNY |
| 31.05.2017 | 0,14 CNY |
Stock Splits
| Date | Split |
|---|---|
| 10.06.2021 | 6:5 |
| 25.05.2020 | 6:5 |
| 28.03.2019 | 6:5 |
Ticker Symbols
| Name | Symbol |
|---|---|
| SSE | 600276.SS |